Greece should not give humiliating low prices at the basic and (already) cheap drugs. Otherwise there is risk that they will disappear from the market.

The prices of prescription drugs in Greece are set by the state.

A usual feature in the Greek drug pricing policy, is to give to basic and (already) cheap drugs a very low retail price so that they disappear from the market. Νobody monetize to sell them in the Greek market. On the contrary some gain money by exporting these drugs to other European countries. When these basic and (already) cheap drugs are out of the way, then the road is open to sell newer similar but much more expensive drugs. 

An example: The basic and (already) cheap antidepressant Amitriptiline.

Eventually we can find Amitriptyline in Greece too (For years it was extinct from the Greek market).   

I fear that it will disappear again because of its pricing:

In Greece, on the 10/24/2014

Tabl. Stelminal (= Amitriptyline) 10 mg x 100 ((i.e. a box with 100 tablets of Stelminal 10 mg) has a retail price of 2.62 Euro

http://www.galinos.gr/web/drugs/main/packages/4738#content

and 

Tabl. Stelminal 25 mg x 50 has a retail price of 1.91 Euro.

http://www.galinos.gr/web/drugs/main/packages/4737#content




On the same date in Sweden the only generic amitriptyline in the market is Amitripytlin Abcur, and it has the following retail prices​​:

Tabl. Amitriptylin Abcur 10 mg x 100 has a retail price of 72 SEK = 7,83 Euro.

http://www.fass.se/LIF/product?userType=0&nplId=20130705000020

and 

Tabl. Amitriptylin Abcur 25 mg x 100 ha a retail price of 94 SEK = 10,22 Euro.

http://www.fass.se/LIF/product?userType=0&nplId=20130705000037

( On 10/24/2014,    1 SEK = 0.108791 EUR ).
 
 
We should learn a lesson from the Swedes: They avoid to set humiliating low prices at basic and (already) cheap drugs in order to keep in the market.